Role of plasminogen activator inhibitor-1 in oral tongue squamous cell carcinoma: An immunohistochemical and in vitro analysis-Reference-Cited by-同舟云学术

Role of plasminogen activator inhibitor-1 in oral tongue squamous cell carcinoma: An immunohistochemical and in vitro analysis

Published:2022-02 Issue: Volume:124 Page:104722
ISSN:0014-4800
Container-title:Experimental and Molecular Pathology
language:en
Short-container-title:Experimental and Molecular Pathology

Author:

Mafra Rodrigo Porpino,Sabino Vladimir Galdino,Rolim Larissa Santos Amaral,de Carvalho Cyntia Helena Pereira,Nonaka Cassiano Francisco Weege,Barboza Carlos Augusto Galvão,de Souza Lélia Batista,Pinto Leão Pereira

Publisher

Elsevier BV

Subject

Clinical Biochemistry,Molecular Biology,Pathology and Forensic Medicine

Reference39 articles.

1. A simple novel prognostic model for early stage oral tongue cancer;Almangush;Int. J. Oral Maxillofac. Surg.,2015

2. Effect of serpinE1 overexpression on the primary tumor and lymph node, and lung metastases in head and neck squamous cell carcinoma;Arroyo-Solera;Head Neck,2019

3. Secretome profiling of oral squamous cell carcinoma-associated fibroblasts reveals organization and disassembly of extracellular matrix and collagen metabolic process signatures;Bagordakis;Tumor Biol.,2016

4. Plasminogen activator inhibitor-1: the double-edged sword in apoptosis;Balsara;Thromb. Haemost.,2008

5. Biomarkers in diagnosis and therapy of oral squamous cell carcinoma: a review of the literature;Blatt;J. Craniomaxillofac. Surg.,2017

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Explore the mechanism of Astragalus membranaceus and Poria cocos drug pair in improving immunity based on network pharmacology;Medicine;2024-06-21

2. Antimicrobial peptides as antimicrobials for wound care management: A comprehensive review;Journal of Drug Delivery Science and Technology;2024-05

3. Tumor budding is a prognostic factor in head and neck squamous cell carcinoma: A comprehensive meta-analysis and trial sequential analysis;Critical Reviews in Oncology/Hematology;2024-01